Company Search:
Advanced Search
Sponsored Links
Genetic Technologies Limited - ADR Company Snapshot
Genetic Technologies Limited - ADR operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited - ADR with three other pharmaceutical manufacturers in North America: Cyclacel Pharmaceuticals, Inc. (2018 sales of $150,000.00 of which 100% was Pharmaceutical Products), Pulmatrix Inc ($153,000.00 ), and TG Therapeutics Inc ($152,000.00 of which 100% was License Revenue).

Sales Analysis. Genetic Technologies Limited - ADR reported sales of $146,384.18 for the fiscal year ending June of 2018. This represents a sharp decrease of 62.6% versus 2017, when the company's sales were $390,979.45 .
  Stock Performance Chart for Genetic Technologies Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/23/2019): 2.29
(Figures in U.S. Dollars)
1 Week 29.3%   13 Weeks -9.7%  
4 Weeks -16.1%   52 Weeks -49.4%  
Genetic Technologies Limited - ADR Key Data:
  Ticker: GENE Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 146,384
(Year Ending Jan 2019).
Employees: 56
  Currency: U.S. Dollars Market Cap: 10,087,302
  Fiscal Yr Ends: June Shares Outstanding: 4,406,860
  Share Type: Ordinary Closely Held Shares: 360,558
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.